ClearPoint Neuro

$19.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.36 (+1.87%) Today
-$0.23 (-1.17%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CLPT and other stocks, options, and ETFs commission-free!

About CLPT

Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA. The listed name for CLPT is ClearPoint Neuro, Inc. Common Stock.

CEO
Joseph Michael Burnett
Employees
21
Headquarters
Irvine, California
Founded
1998
Market Cap
331.15M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
306.10K
High Today
$20.44
Low Today
$17.91
Open Price
$20.00
Volume
317.29K
52 Week High
$20.56
52 Week Low
$2.86

Collections

CLPT Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 10, After Hours

You May Also Like

CYRX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure